Skip to main content
C.Q. Pharmaceutical Holding Co., Ltd. logo

C.Q. Pharmaceutical Holding Co., Ltd. — Investor Relations & Filings

Ticker · 000950 ISIN · CNE0000010K0 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,883 across all filing types
Latest filing 2023-04-26 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000950

About C.Q. Pharmaceutical Holding Co., Ltd.

https://www.cqphar.com

C.Q. Pharmaceutical Holding Co., Ltd. is a comprehensive pharmaceutical enterprise specializing in the distribution, retail, and supply chain management of healthcare products. The company operates an extensive network focused on the wholesale of pharmaceuticals and medical devices, providing integrated logistics and warehousing solutions to healthcare providers and manufacturers. Its core business activities encompass the procurement and distribution of a wide range of prescription drugs, over-the-counter medications, and specialized medical equipment. Through its retail pharmacy operations and third-party logistics services, the company facilitates the efficient delivery of medical supplies. C.Q. Pharmaceutical Holding Co., Ltd. emphasizes technological integration within its supply chain to optimize inventory management and ensure the integrity of healthcare products throughout the distribution lifecycle.

Recent filings

Filing Released Lang Actions
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 14th meeting of the 8th Board of Directors of the company. It includes voting results on various agenda items such as election of chairman, appointment and dismissal of senior management, approval of annual reports, financial reports, ESG reports, audit reports, and other governance matters. The document references other announcements and reports but primarily serves as a formal record of board decisions and approvals. It does not contain the full text of financial reports or detailed financial data itself, but rather the board's resolutions and approvals. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management and related board meeting resolutions.
2023-04-26 Chinese
关于计提减值准备的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company regarding the provision for asset impairment, including detailed figures and explanations about the impairment testing and its impact on financial results for the year ended December 31, 2022. It references accounting standards and regulatory guidelines, and it is signed by the board. The document is relatively short (2159 characters) and focuses on a specific accounting adjustment rather than presenting a full financial report. It does not contain comprehensive financial statements or a full annual or interim report. It is a regulatory announcement about an accounting provision, not a full audit report or annual report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such announcements that do not fit other specific categories.
2023-04-26 Chinese
关于拟变更公司董事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding a proposed change in the company's board of directors, specifically the nomination of a new non-independent director. It includes details about the nominee's background and confirms compliance with relevant laws and regulations. There is no financial data, earnings information, or report publication mentioned. The content clearly fits the category of Board/Management Information, as it pertains to changes in the company's board members.
2023-04-26 Chinese
独立董事关于公司第八届董事会第十四次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion statement from the independent directors of a company regarding various corporate governance matters discussed at a board meeting. It includes opinions on the internal control evaluation report, the appointment of the audit firm for the annual report, profit distribution proposals, related party transactions, and changes in senior management and board members. The document references the 2022 annual internal control evaluation and audit firm appointment for 2023, but it does not contain actual financial statements or detailed financial data. Instead, it provides independent directors' opinions on these matters and confirms compliance with laws and regulations. The document is related to board/management information, specifically about board meeting decisions and management changes, rather than being a full annual report, audit report, or other financial report. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is 2536 characters, which is relatively short and consistent with a board opinion or announcement rather than a full report.
2023-04-26 Chinese
年度关联方资金占用专项审计报告
Audit Report / Information Classification · 95% confidence The document is a detailed special explanation regarding the use of funds by controlling shareholders and other related parties for the fiscal year 2022. It includes audited financial data, references to the audit report with a standard unqualified opinion dated April 25, 2023, and compliance with regulatory requirements from Chinese securities and regulatory authorities. The document contains tables summarizing non-operating fund occupation and related party transactions, with detailed financial figures and accounting notes. It is not a full annual report but a standalone audit-related disclosure focusing on a specific regulatory compliance topic related to fund occupation and related party transactions. The presence of an audit report reference and detailed financial data related to audit and regulatory compliance indicates this is an Audit Report / Information filing rather than a general annual report or other category. The document length (15,000 characters) and content confirm it is not a mere announcement or certification but a substantive audit-related report.
2023-04-26 Chinese
独立董事关于第八届董事会第十四次会议相关事项的事前认可意见
Board/Management Information Classification · 95% confidence The document is a statement from independent directors regarding pre-approval opinions on several agenda items for the company's board meeting, including the reappointment of the annual audit firm for 2023 and internal control audit firm, as well as related party transactions for 2023. It references compliance with corporate governance rules and regulatory requirements but does not contain actual financial statements or detailed financial data. The document is short (1197 characters) and serves as a governance-related opinion or announcement rather than a full audit report or annual report. It is not a certification letter, nor a report publication announcement. The content aligns best with Board/Management Information (MANG) as it relates to board meeting matters and approvals involving audit firms and related party transactions.
2023-04-26 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.